Canaccord downgraded Verve Therapeutics (VERV) to Hold from Buy with a price target of $13, down from $39, after Eli Lilly (LLY) announced a definitive agreement to acquire Verve. Lilly will commence ...

Wall Street remained steady as investors awaited the Federal Reserve's policy decision, while global markets reacted to ...

U.S. stocks are holding nearly in place as Wall Street waits to hear where the Federal Reserve may be taking interest rates.

Asian shares were mixed and oil prices advanced Wednesday after the escalation of conflict in the Middle East hit Wall Street. US benchmark crude oil was up 24 cents at $73.51 per barrel. Brent crude, ...

The UK’s National Institute for Health and Care Excellence (NICE) has today recommended Spevigo (spesolimab) for the ...

A study presented at the American Society for Metabolic and Bariatric Surgery highlighted that bariatric surgeries, ...